GDF‐15 prevents platelet integrin activation and thrombus formation

Savage, 1998, Specific synergy of multiple substrate‐receptor interactions in platelet thrombus formation under flow, Cell, 94, 657, 10.1016/S0092-8674(00)81607-4 Nieswandt, 2003, Platelet‐collagen interaction: is GPVI the central receptor?, Blood, 102, 449, 10.1182/blood-2002-12-3882 Shattil, 2004, Integrins: dynamic scaffolds for adhesion and signaling in platelets, Blood, 104, 1606, 10.1182/blood-2004-04-1257 Ginsberg, 2005, Integrin regulation, Curr Opin Cell Biol, 17, 509, 10.1016/j.ceb.2005.08.010 Bhatt, 2003, Scientific and therapeutic advances in antiplatelet therapy, Nat Rev Drug Discovery, 2, 15, 10.1038/nrd985 Kempf, 2011, GDF‐15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice, Nat Med, 17, 581, 10.1038/nm.2354 Quinn, 2003, Integrin alphaIIbbeta3 and its antagonism, Arterioscler Thromb Vasc Biol, 23, 945, 10.1161/01.ATV.0000066686.46338.F1 Chew, 2001, Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta‐analysis of phase III multicenter randomized trials, Circulation, 103, 201, 10.1161/01.CIR.103.2.201 Hsiao, 2000, Characterization of growth‐differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury, Mol Cell Biol, 20, 3742, 10.1128/MCB.20.10.3742-3751.2000 Petrich, 2007, The antithrombotic potential of selective blockade of talin‐dependent integrin alpha IIb beta 3 (platelet GPIIb‐IIIa) activation, J Clin Invest, 117, 2250, 10.1172/JCI31024 Zarbock, 2010, Chemokine homeostasis vs. chemokine presentation during severe acute lung injury: the other side of the Duffy antigen receptor for chemokines, Am J Physiol Lung Cell Mol Physiol, 298, L462, 10.1152/ajplung.00224.2009 Marx, 2008, Altered thrombus formation in von Willebrand factor‐deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa, Blood, 112, 603, 10.1182/blood-2008-02-142943 Kuwano, 2010, Rolling on E‐ or P‐selectin induces the extended but not high‐affinity conformation of LFA‐1 in neutrophils, Blood, 116, 617, 10.1182/blood-2010-01-266122 Zarbock, 2007, Spleen tyrosine kinase Syk is necessary for E‐selectin‐induced alpha(L)beta(2) integrin‐mediated rolling on intercellular adhesion molecule‐1, Immunity, 26, 773, 10.1016/j.immuni.2007.04.011 Zarbock, 2008, PSGL‐1 engagement by E‐selectin signals through Src kinase Fgr and ITAM adapters DAP12 and FcR gamma to induce slow leukocyte rolling, J Exp Med, 205, 2339, 10.1084/jem.20072660 Stadtmann, 2011, Rap1a activation by CalDAG‐GEFI and p38 MAPK is involved in E‐selectin‐dependent slow leukocyte rolling, Eur J Immunol, 41, 2074, 10.1002/eji.201041196 Lenter, 1993, A monoclonal antibody against an activation epitope on mouse integrin chain beta 1 blocks adhesion of lymphocytes to the endothelial integrin alpha 6 beta1, Proc Natl Acad Sci U S A., 90, 9051, 10.1073/pnas.90.19.9051 de Bruyn, 2003, The small GTPase Rap1 is activated by turbulence and is involved in integrin [alpha]IIb[beta]3‐mediated cell adhesion in human megakaryocytes, J biol chem, 278, 22412, 10.1074/jbc.M212036200 Bergmeier, 2002, Flow cytometric detection of activated mouse integrin alphaIIbbeta3 with a novel monoclonal antibody, Cytometry, 48, 80, 10.1002/cyto.10114 Ruggeri, 2002, Platelets in atherothrombosis, Nat Med, 8, 1227, 10.1038/nm1102-1227 Hoffmeister, 2008, Cyclic nucleotide‐dependent protein kinases inhibit binding of 14‐3‐3 to the GTPase‐activating protein Rap1GAP2 in platelets, J biol chem, 283, 2297, 10.1074/jbc.M706825200 Hodivala‐Dilke, 1999, Beta3‐integrin‐deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival, J Clin Investig, 103, 229, 10.1172/JCI5487 Shattil, 1995, Function and regulation of the beta 3 integrins in hemostasis and vascular biology, Thromb Haemost, 74, 149, 10.1055/s-0038-1642668 Ni, 2000, Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen, J Clin Investig, 106, 385, 10.1172/JCI9896 Nurden, 2006, Glanzmann thrombasthenia, Orphanet J Rare Dis, 1, 10, 10.1186/1750-1172-1-10 Crittenden, 2004, CalDAG‐GEFI integrates signaling for platelet aggregation and thrombus formation, Nat Med, 10, 982, 10.1038/nm1098 Bergmeier, 2007, Mice lacking the signaling molecule CalDAG‐GEFI represent a model for leukocyte adhesion deficiency type III, J Clin Investig, 117, 1699, 10.1172/JCI30575 Kristensen, 2012, Contemporary use of glycoprotein IIb/IIIa inhibitors, Thromb Haemost, 107, 215, 10.1160/TH11-07-0468 Bassler, 2007, A mechanistic model for paradoxical platelet activation by ligand‐mimetic alphaIIb beta3 (GPIIb/IIIa) antagonists, Arterioscler Thromb Vasc Biol, 27, e9, 10.1161/01.ATV.0000255307.65939.59